Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Peter Campochiaro

Peter Anthony Campochiaro, MD

George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience
Professor of Ophthalmology

See Research on Pubmed

Male
Appointment Phone

410-955-3518

Main Location

Johns Hopkins Wilmer Eye Institute

View All Locations
Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-0773 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience
  • Professor of Ophthalmology

Centers & Institutes

  • Wilmer Eye Institute Research

Expertise

Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Age-Related, Macular Holes, Macular Puckers, Ophthalmology, Proliferative Vitreoretinopathy, Retinal Detachment, Retinal Vessel Occlusion

Research Interests

Ocular Gene Therapy; Clinical trials of ocular neovascularization and macular edema; Development of new treatments for retinal degenerations; Mechanisms involved in retinal degenerations; Development of new treatments for ocular neovascularization; Mechanisms involved in ocular neovascularization

Biography

Dr. Campochiaro was trained at the University of Notre Dame, Johns Hopkins School of Medicine, the University of Virginia, and Wilmer, joining the Wilmer Faculty in 1991. He is currently the George S. and Dolores Dor Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Institute. His major research interests are in gaining a greater understanding of the roles of peptide growth and trophic factors in the retina and retinal pigmented-epithelium with an ultimate goal of developing new treatments for proliferative retinopathies, choroidal neovascularization and retinal degenerations.

Languages

  • English

Clinical Trial Keywords

  • Diabetic macular edema
  • Ranibizumab
  • Central retinal vein occlusion
  • Branch retinal vein occlusion
  • Choroidal neovascularization
  • Gene therapy
Additional Resources +

Is This You? Edit Profile

 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer